Medidata Rave RCM 與 Preclarus 使用情況與統計

Quick & easy access to the regulated content you need when you need it. Medidata’s Rave Regulated Content Management (RCM) iOS application allows you to securely access and manage content anytime from anywhere. A streamlined version of the full featured desktop version, the iOS experience has a familiar user interface that’s optimized for mobile screens with the tools you need to manage content & workflows on-the-go. The Rave RCM iOS app is built and managed to the highest standards of validation and security with 21 CFR Part 11 compliance. With Medidata RCM, you can: · Quickly & easily find folders & documents – with an intuitive folder based structure, powerful search and user centric features like Favorites & Recent Documents, finding what you need has never been easier. · View & inspect documents – document previews with watermarks, approver tables and version information. Document Details provides extensive information like Owner, Format, State, etc. · Manage document workflows – approve tasks using the iOS Touch ID feature and provide & review comments as documents go through the workflow lifecycle: from Authorization to Approval.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

Use your existing Preclarus Investigator Site Portal account to manage your clinical trials on your mobile device. The Preclarus mobile application provides the following functionality: • Test results review including graphing and trending • Alert review and query resolution • Subject registration • Online specimen accessioning using Generated and Foreign Barcodes • Shipment/specimen tracking • Supply ordering and inventory management • Full integration of data with the web-based version in real time
  • Apple App Store
  • 免費版
  • 健康與健身

商店排名

- -

Medidata Rave RCM與 Preclarus 比較排名

比較過去 28 天的 Medidata Rave RCM 排名趨勢與 Preclarus

排名

無可用數據

各國 Medidata Rave RCM vs. Preclarus 排名比較

比較過去 28 天的 Medidata Rave RCM 排名趨勢與 Preclarus

無可顯示數據

使用我們的免費試用版,與所有網站進行比較

立即開始
Medidata Rave RCM VS.
Preclarus

12月 19, 2024